title: High-dose tumor necrosis factor-alpha leads to the systemic inflammatory response syndrome.
authors.affiliation: Klinik für Abdominal- und Transplantationschirurgie, Klinische Molekularpharmakologie, Medizinische Hochschule Hannover, Germany.
authors.forename: K J
authors.initials: KJ
authors.lastname: Oldhafer
authors.forename: H
authors.initials: H
authors.lastname: Lang
authors.forename: E R
authors.initials: ER
authors.lastname: Kuse
authors.forename: M U
authors.initials: MU
authors.lastname: Martin
mesh_terms: D000328:Adult; D006801:Humans; D008113:Liver Neoplasms / Q000188:drug therapy; D008297:Male; D018746:Systemic Inflammatory Response Syndrome / Q000139:chemically induced*; D014409:Tumor Necrosis Factor-alpha / Q000008:administration & dosage / Q000009:adverse effects*
chemical_list: D014409:Tumor Necrosis Factor-alpha